Nexplanon 68 MG implants
Ended Awarded
- Contract number
- SPE2DB26FXGVQ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $10,415
Award facts
- Contract value 100% obligated
- $10,414.65 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency has awarded a delivery order valued at $10,414.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nexplanon 68 mg implants. This delivery order, issued on October 28, 2025, with an ultimate completion date of November 19, 2025, operates under a firm fixed-price structure with no set-aside designation, indicating the award was made through unrestricted federal procurement competition. DMS Pharmaceutical Group is performing under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a broader $30.3 billion Defense Logistics Agency acquisition strategy designed to establish multiple regional prime vendor contractors to support Department of Defense pharmaceutical supply requirements.
The PPV-G GEN V contract vehicle through which this delivery order was issued carries a ceiling value of $499,999,999 and extends through December 31, 2036, encompassing a 30-month base period with three optional 30-month extension periods. This acquisition structure enables the Defense Logistics Agency to issue firm fixed-price delivery orders for comprehensive pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables, to support recurring medical supply needs across military healthcare facilities worldwide. DMS Pharmaceutical Group's selection as a prime vendor contractor reflects its established performance capability in supplying specialized pharmaceutical products and its critical role within the federal military medical supply chain.
Quick answers
Who was awarded contract SPE2DB26FXGVQ?
SPE2DB26FXGVQ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on October 28, 2025.
How much is contract SPE2DB26FXGVQ worth?
The government has obligated $10,415 on SPE2DB26FXGVQ.
Is contract SPE2DB26FXGVQ an order under another contract?
Yes. SPE2DB26FXGVQ is a delivery order under SPE2DB25D9306, an indefinite delivery contract.
Was contract SPE2DB26FXGVQ competed?
The extent of competition for SPE2DB26FXGVQ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award